Public Health Emergency Medicine in USA

Question: Describe about FDA alerts health care professionals and patients not to use products from the Prescription Center pharmacy in Fayetteville, N.C.? Answer: In now a day, the people or patients of the United States of America could not use the medicine, which is produced and distributed by Prescription Center pharmacy. The Prescription Center pharmacy is situated in 915 Hay St. Fayetteville, near North Carolina. Before of some month ago, the United States Food and Drugs Organization were collaborate with the North Carolina Board of Pharmacy (NC BOP) (fda.gov, 2015). Both of the organization or administration are produce and distributed health care products to the market of the United States in America but suddenly according to some scrutiny or examination by the government body it is clear that the patients or people did not use the health care products or medicine, which is basically manufacture as well as distributed by the North Carolina Board of Pharmacy (NC BOP). The produced health care products of the North Carolina Board of Pharmacy (NC BOP) are basically examine and inspect and it is clearly found some side effects of the products and by the using or the health care products and medicine so many people are facing some unwanted diseases. For that reason the health care products as well as the medicine was not in use. Mainly the defective products are found in the distributed health care products and medicine in duration between at 10th September, 2014 to 10th March, 2015. The main issue of avoid the health care products and medicine of North Carolina Board of Pharmacy (NC BOP) is due to its quality. References (2015). Retrieved 3 April 2015, from https://FDA alerts health care professionals and patients not to use products from the Prescription Center pharmacy in Fayetteville, N.C. Fda.gov,. (2015).FDA alerts health care professionals and patients not to use products from the Prescription Center pharmacy in Fayetteville, N.C.. Retrieved 3 April 2015, from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm440974.htm